MTEM

Why Molecular Templates Stock Crashed Today

Molecular Templates Stock Falls After It Stops MT-3724 Development In Hematological Malignancies

Molecular Templates to Prioritize Next-Generation ETB Candidates

Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results

Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock

Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

Molecular Templates, Inc. Provides Update on MT-5111 Phase 1 Study